Treating Atypical Hemolytic Uremic Syndrome A Case Discussion

Slides:



Advertisements
Similar presentations
Where Are We on the Path to Elimination of Chronic Hepatitis C?
Advertisements

Case-Based Examination of Treatment Options in Type 2 Diabetes Management.
The Nurse View: Management of Pancreatic Cancer
Timely Diagnosis of Gastroenteritis: Implications for Patients and Public Health.
A Framework for Diagnosing and Treating CTEPH
ICD-10 and Clinical Documentation
Challenges and Opportunities in the Management of ANCA-Associated Vasculitis.
NOACs for Cancer-Associated Thrombosis:
Volume 89, Issue 3, Pages (March 2016)
Starting Strong: Initial Evaluation of the Patient With HCV
Improving the Diagnosis and Treatment of Seizures in Long-term Care
MR Imaging in Children.
Optimizing Outcomes in Short Bowel Syndrome With IF
Essential Updates in Atopic Dermatitis:
Updates in Hodgkin Lymphoma
Glaucoma Progression.
Pediatric Antiepileptic Treatment Strategies
Ask the Onychomycosis Expert, Part 2
The Role of Imaging in Diagnosing IPF Hands-On Case Studies
Hunter Syndrome: Why We Need to Diagnose and Treat Early
Extended Half-life Factor Products in the Management of Hemophilia
How to Achieve Aggressive BP Goals in Difficult-to-Treat Patients
Advances in Dry Eye.
The Nurse View: Overcoming Challenges Associated With Cancer Immunotherapy.
The Nurse View: Updates in the Management of Metastatic Colorectal Cancer.
Bone Biology and Osteoporosis: Back to the Basics
More Than Treatment.
Clinical Considerations in Evidence-based Management of GIST
Evaluation of the Patient With HCV Infection
الفعل ورد الفعل ♠ ♠ ♠ مجلس أبوظبي للتعليم منطقة العين التعليمية
Treating HFrEF: Challenges Faced
Team-Based Perspectives on Successful Approaches in Treating Obesity
Overview. Maximizing the Safety of CAR T-Cell Therapy: Prevention, Early Recognition, and Management.
Seizures in the Elderly: Treatment and Special Considerations
The Nurse View: Targeted Therapies for the Patient With Metastatic Colorectal Cancer.
Antithrombotic Protection in CAD and HF
Targeting Osteoporosis Therapies to Patients at Highest Risk for Fracture.
Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?
Discontinuation of Eculizumab in a Patient With Atypical Hemolytic Uremic Syndrome Due to a Mutation in CFH  Sandra Habbig, MD, Carsten Bergmann, MD,
How I treat catastrophic thrombotic syndromes
Advancing the Treatment of IBD With Biologics
Bone Biology and Osteoporosis: Back to the Basics
Hyperammonemia: Best Practices for Diagnosis and Treatment
Nurse View: Practice Pearls in Advanced Pancreatic Adenocarcinoma
Traditional Stimulants vs Other Wake-Promoting Agents
Program Goals. Accurate Diagnosis and Treatment of Patients With Thrombotic Microangiopathy.
US and European Perspectives on Sinusoidal Obstruction Syndrome
Considerations in the Management of Viper Bite
Scientific Update.
Cancer-Associated Thrombosis
Viewpoints of Practicing Rheumatologists: Case Discussions in RA
Extended Half-life Factor Products in the Management of Hemophilia
Program Goals Disclaimers Defining Refractory Seizures.
Breaking News in Pemphigus Vulgaris and the Latest Updates for Your Practice.
Bone Biology and Osteoporosis: Back to the Basics
Communicating With Your Patients About Major Depressive Disorder
Incorporating Prostacyclins Into Practice
Perspective on the Multidisciplinary Management of PAH
Program Goal. Program Goal Disclaimer Overview.
Disease Burden of VTE Phases of VTE Treatment.
Educational Objectives
Renal Function and Myeloma Therapeutics
Program Goals Overview Is NEDA a Reasonable Target?
Selecting Treatment Approaches in Hemophilia
Diagnosing Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome
So Many Guidelines, So Little Time:
Issues in Patients With Severe Epilepsy
Clinical Considerations in Evidence-based Management of GIST
Volume 54, Issue 4, Pages (October 1998)
The Building Blocks of Homocystinuria and Homocysteinemia Management
Presentation transcript:

Treating Atypical Hemolytic Uremic Syndrome A Case Discussion

Activity Goals

A Child With TMA Initial Presentation

Laboratory Values on Admission

Additional Laboratory Values and Examination

Additional Laboratory Values and Examination (cont)

Diagnosis

Extended Testing

Adverse Reactions Reported in ≥ 10% of Treated Pediatric Patients

Treatment Summary

Abbreviations

Abbreviations (cont)

Abbreviations (cont)

References

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)